The research compound in Vyleesi®
Vyleesi® is a hypoactive sexual desire disorder medicine from Cosette Pharmaceuticals. Its active compound is PT-141 — which is what this catalogue supplies, as a research material.
This is not Vyleesi®, and NOVALYTE LABS has no affiliation with Cosette Pharmaceuticals. We supply the compound PT-141 for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Vyleesi® is a trademark of Cosette Pharmaceuticals, referenced here only to identify the compound.
Vyleesi is the brand for bremelanotide, the compound also known in research contexts as PT-141.
It is a melanocortin receptor agonist acting on MC3R and MC4R in the central nervous system — a mechanism distinct from the vascular one used by the older oral agents in that area.
PT-141 is listed here as a research material with batch documentation, not as the branded medicine.
PT-141 in this catalogue
10mg vial
How PT-141 is supplied here
Everything below describes the research material in this catalogue, not the medicine.
| Compound | PT-141 |
|---|---|
| Presentation | 10mg vial |
| Dosage options | 10mg |
| Research category | Neuro Research |
| Batch COA | Certificate supplied with order |
| Availability | In stock |
| Intended use | Laboratory research only — not for human or veterinary use |
Common questions
What is the active compound in Vyleesi?
PT-141. Vyleesi is a registered trademark of Cosette Pharmaceuticals, approved for hypoactive sexual desire disorder.
Is this Vyleesi?
No. NOVALYTE LABS supplies PT-141 as a research material with batch documentation. It is not Vyleesi, it is not a medicine, it is not supplied for human use, and there is no affiliation with Cosette Pharmaceuticals.
Can I buy Vyleesi here?
No. Vyleesi is a prescription medicine sold by Cosette Pharmaceuticals. This catalogue supplies PT-141, the compound it is built on, as a laboratory research material only.